TITLE

Clopidogrel unaffected by CYP2C19 loss-of-function alleles in patients with ACS, AF

PUB. DATE
December 2010
SOURCE
Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p34
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on a study which revealed that clopidogrel was unaffected by CYP2C19 loss-of-function allele status for patients with acute coronary syndromes or atrial fibrillation.
ACCESSION #
56533949

 

Related Articles

  • The P450 system and CV outcomes with clopidogrel.  // Primary Care Reports;Jan2011 Clinical Briefs in Primary, Vol. 16 Issue 1, p1 

    The article discusses a research study conducted on subjects with atrial fibrillation or post-acute coronary syndrome (ACS) who were exposed to clopidogrel and received CYP2C19, concluding that the P450 system and clopidogrel do not ensure positive effects on cardiovascular outcomes or bleeding...

  • The P450 system and CV outcomes with clopidogrel.  // Critical Care Alert;Jan2011 Clinical Briefs in Primary, p1 

    No abstract available.

  • The P450 system and CV outcomes with clopidogrel.  // Clinical Cardiology Alert;Jan2011 Clinical Briefs, p1 

    No abstract available.

  • The P450 system and CV outcomes with clopidogrel.  // Clinical Oncology Alert;Jan2011 Supplement 2, p1 

    No abstract available.

  • Clopidogrel.  // Reactions Weekly;2/4/2012, Issue 1387, p14 

    The article describes the case of an 84-year-old man with acute coronary syndrome who developed neutropenia while being treated with clopidogrel.

  • Upper gastrointestinal bleed in a post menopausal woman due to combination of high first dose aspirin and clopidogrel prescribed for acute coronary syndrome. Tandon, Vishal R.; Maqbool, Rubeena; Kahkashan, Iram; Sharma, Rashmi; Khajuria, Vijay; Gillani, Zahid // Journal of Mid-life Health;Jul-Sep2015, Vol. 6 Issue 3, p129 

    Combination of aspirin, clopidogrel and enoxaparin remains the standard treatment for acute coronary syndrome (ACS) but is known to increase the incidence of upper gastrointestinal bleed (UGIB). We hereby report an unusual case of gastrointestinal bleed (GIB) as it resulted inspite of proton...

  • Untitled. Böhm, Michael // MD Conference Express;Oct2011, p3 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the benefits of the oral factor Xa inhibitor apixaban, treatment for atrial fibrillation, and acute coronary syndrome (ACS).

  • Atrial Fibrillation in Acute Coronary Syndrome. Rubenstein, Jason C.; Cinquegrani, Michael P.; Wright, Jennifer // JAFIB: Journal of Atrial Fibrillation;Jun2012, Vol. 2 Issue 11, p1 

    Atrial fibrillation (AF) is a common cardiac arrhythmia occurring in an estimated 2.7 to 6.1 million people in the United States. The risk factors for the development of AF are very similar to those for developing coronary artery disease, and AF is often associated with acute coronary syndrome...

  • THE EVALUATION TO THE EFFICACY AND SAFETY OF TIROFIBAN IN ACUTE CORONARY SYNDROME PATIENTS WITH CLOPIDOGREL RESISTANCE DURING PERCUTANEOUS CORONARY INTERVENTION.  // Heart;Oct2010 Supplement, pA196 

    An abstract of the article "The Evaluation to the Efficacy and Safety of Trofiban in Acute Coronary Syndrome Patients With Clopidogrel Resistance During Percutaneous Coronary Intervention" by Fu Xianghua, Gu Xinshun, Chai Qiaoyi and colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics